Predict your next investment

Venture Capital
glsv-vc.com

See what CB Insights has to offer

Investments

70

Portfolio Exits

19

Funds

3

About Global Life Science Ventures

GLSV is an independent venture capital fund focusingexclusively on the life sciences. With offices in Switzerland andGermany, GLSV is dedicated to supporting early-stage companiesoriginating from universities, scientific institutions or industry,but also invests in selected later-stage companies, includingbuy-outs. The group currently advises aims to manage funds totaling morethan EUR 200 million. GLSV has now financed 33 innovative life sciencecompanies throughout Europe and the USA, thirteen of which havecompleted an exit through IPO, trade sale or M&A. Since 1996, GLSVhas built up a broadly diversified portfolio of companies inpharmaceuticals, diagnostics, medical devices, and biotechnology.Global Life Science Ventures Industry-born team - Proven track record - Global perspective.

Global Life Science Ventures Headquarter Location

Tal 26

Munich, D-80331,

Germany

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Global Life Science Ventures News

Investments in Minnesota Life Science Firms Reach Six Year High in 2014 Up 23 from 2013

Jan 15, 2015

Global Life Science Ventures GmbH - Medical Equipment - Investment Profile LifeScience Alley announces today that 86 Minnesota-based companies within the life science industry collectively raised $430.4 million in 2014, representing the highest level of investment activity in the industry since 2009. Investments in Minnesota’s medical device sector reached a six year high at $322 million, a 6.3% increase over 2013. “2014 was a record year for all life science investing activity and within many of the individual sectors we cover,” said Cheryl Matter, PhD, director of intelligence and research for LifeScience Alley. “The data and increasing trends over the last six years indicate that Minnesota's life science industry is healthy and growing, and that investment opportunities still abound to help these companies. " These findings come from LifeScience Alley’s "Minnesota Life Science Investment Activity" report series, which compiles quarterly data on a variety of investment types from various sources for early-stage and emerging companies in the medical device, pharmaceuticals and biotechnology , health information technology, and diagnostics and research tools sectors. Total 2014 life science investing was up $81.8 million, a 23% increase over 2013 and a 71% increase over 2012. Although medical device companies attracted record high investment dollars, 2014 saw increased diversification of sectors securing investment, with significant spikes in both the number of companies receiving funds and total dollars invested within the pharmaceuticals/biotechnology and health information technology sectors. Raising $49 million, the pharmaceuticals and biotechnology sector saw a 10-fold increase over 2013 investment levels ($4 million). Minnesota's rapidly growing health information technology sector saw investment levels up 41% over 2013 at $41 million raised, continuing an increasing trend in that space. Another trend driving investment growth is the increase in companies raising large figures. This year, 17 companies raised $7 million or more (compared to 11 companies in 2013) and 26 companies raised $3 million or more (compared to 22 companies in 2013). The medical device sector accounted for 71% of the companies raising $7 million or more. 2014 also saw the highest median levels of investing activity yet, with a median of $3.9 million in quarter three and $2.4 million in quarter four. For the first time during the years tracked, the fourth quarter saw higher investment levels than the historically strongest third quarter, with $119 million raised, a 17% increase over 2013. In addition to recording high levels of life science investment activity, 2014 saw more than $1 billion in liquidity events in the life science industry, with transactions in the health information technology sector accounting for approximately $780 million. About LifeScience Alley LifeScience Alley is a global leader in enabling life science business success with a 30-year track record of delivering results-oriented outcomes. We are committed to leading the conversation in improving our community’s operating environment and supporting advancement in research and healthcare innovation. By influencing proactive policy change, delivering vital information and intelligence, leading solutions-based initiatives and uniting members with critical resources, LifeScience Alley works to ensure that collectively Minnesota’s Medical Alley remains the world's strongest health technology community. The Association’s membership and supporting community extends throughout the world, employing more than 300,000 Minnesotans and many more globally. Learn more at www.LifeScienceAlley.org . LifeScience Alley

Global Life Science Ventures Investments

70 Investments

Global Life Science Ventures has made 70 investments. Their latest investment was in Nabriva Therapeutics as part of their Series B on April 4, 2015.

CBI Logo

Global Life Science Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/7/2015

Series B

Nabriva Therapeutics

$120M

No

5

6/22/2012

Convertible Note

Santaris Pharma

$12M

No

1/1/2012

Series A

Pixium

$11.9M

Yes

1

12/11/2009

Debt

Subscribe to see more

$99M

Subscribe to see more

0

10/28/2009

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/7/2015

6/22/2012

1/1/2012

12/11/2009

10/28/2009

Round

Series B

Convertible Note

Series A

Debt

Series A

Company

Nabriva Therapeutics

Santaris Pharma

Pixium

Subscribe to see more

Subscribe to see more

Amount

$120M

$12M

$11.9M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

5

1

0

10

Global Life Science Ventures Portfolio Exits

19 Portfolio Exits

Global Life Science Ventures has 19 portfolio exits. Their latest portfolio exit was Nabriva Therapeutics on September 18, 2015.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/18/2015

IPO

$99M

Public

1

12/18/2014

Reverse Merger

$99M

2

8/4/2014

Acquired

$99M

1

6/17/2014

IPO

Subscribe to see more

$99M

Subscribe to see more

10

4/17/2013

Acq - P2P

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/18/2015

12/18/2014

8/4/2014

6/17/2014

4/17/2013

Exit

IPO

Reverse Merger

Acquired

IPO

Acq - P2P

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

2

1

10

10

Global Life Science Ventures Fund History

3 Fund Histories

Global Life Science Ventures has 3 funds, including Global Life Science Ventures Fonds II LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2002

Global Life Science Ventures Fonds II LP

Multi-Stage Venture Capital

Closed

$180M

1

12/31/1996

Global Life Science Fund LP

Subscribe to see more

Subscribe to see more

$99M

10

Global Life Science Ventures Fonds III LP

Subscribe to see more

Subscribe to see more

10

Closing Date

12/31/2002

12/31/1996

Fund

Global Life Science Ventures Fonds II LP

Global Life Science Fund LP

Global Life Science Ventures Fonds III LP

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Amount

$180M

$99M

Sources

1

10

10

Global Life Science Ventures Team

1 Team Member

Global Life Science Ventures has 1 team member, including former Controller, Ralf Johnsen.

Name

Work History

Title

Status

Ralf Johnsen

Controller

Former

Name

Ralf Johnsen

Work History

Title

Controller

Status

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.